Cargando…

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective

OBJECTIVE: Ivabradine, a specific heart rate lowering therapy, has been shown in a randomised placebo-controlled study, Systolic HF Treatment with the I(f) Inhibitor Ivabradine Trial (SHI(f)T), to significantly reduce the composite end point of cardiovascular death and hospitalisation for worsening...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffiths, A, Paracha, N, Davies, A, Branscombe, N, Cowie, M R, Sculpher, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Heart Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078716/ https://www.ncbi.nlm.nih.gov/pubmed/24634022 http://dx.doi.org/10.1136/heartjnl-2013-304598

Ejemplares similares

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
por: Woods, B, et al.
Publicado: (2015)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Ivabradine, the pure heart rate-lowering drug, shown to reduce morbidity and mortality in heart failure
Publicado: (2010)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Impact of missed treatment opportunities on outcomes in hospitalised patients with heart failure
por: Walker, Simon, et al.
Publicado: (2017)

Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial
por: Griffiths, Alison, et al.
Publicado: (2017)

Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals
por: Cheang, Mun Hong, et al.
Publicado: (2015)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Mortality after admission for heart failure in the UK compared with Japan
por: Nagai, Toshiyuki, et al.
Publicado: (2018)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)

Gaps in Modern Heart Failure and Chronic Kidney Disease Research
por: Parmar, Simran Singh, et al.
Publicado: (2023)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018)

Heart Failure in a Child: Multimodality Approach Leading to an Unusual Cause
por: Karuru, Uma Devi, et al.
Publicado: (2021)

Associations of short‐ and long‐term mortality with admission blood pressure in Chinese patients with different heart failure subtypes
por: Chen, Shilan, et al.
Publicado: (2022)

Changes in heart failure management and long-term mortality over 10 years: observational study
por: Bottle, Alex, et al.
Publicado: (2022)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model
por: Tran, Patrick, et al.
Publicado: (2022)

Severe Hypoxemia Caused by High-Output Heart Failure and Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
por: Yamamoto, Hiroaki, et al.
Publicado: (2021)

Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
por: Putri, Desak Ketut Sekar Cempaka, et al.
Publicado: (2023)

Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation
por: Sugimura, Yukiharu, et al.
Publicado: (2023)

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
por: Iguchi, Moritake, et al.
Publicado: (2023)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Prevalence of P wave dispersion and interatrial block in patients with systolic heart failure and their relationship with functional status, hospitalization and one year mortality
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

Living with heart failure: perspectives of ethnic minority families
por: Shamali, Mahdi, et al.
Publicado: (2020)

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure
por: Norhammar, Anna, et al.
Publicado: (2023)

Real-world presentation with heart failure in primary care: do patients selected to follow diagnostic and management guidelines have better outcomes?
por: Bottle, Alex, et al.
Publicado: (2018)

GP perceptions of the adequacy of community-based care for patients with advanced heart failure in a UK region (NI): a qualitative study
por: Chen, Jingwen Jessica, et al.
Publicado: (2018)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK
por: Sundaram, Varun, et al.
Publicado: (2022)

The impact of an integrated heart failure service in a medium-sized district general hospital
por: Hawley, Alasdair, et al.
Publicado: (2020)

IMPACT OF HEART FAILURE ON COVID-19 PNEUMONIA HOSPITALIZATIONS: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2020
por: Atluri, Ramtej, et al.
Publicado: (2023)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance
por: Zheng, Alice, et al.
Publicado: (2020)

In-hospital treatment and outcomes of heart failure in specialist and non-specialist services: a retrospective cohort study in the elderly
por: Parmar, Kishan R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4jntqmub2uh0d1p3ftrv5pjm78